+321 123 4567
info@test.com
My Account
  1. Home
  2. /
  3. Availability
  4. /
  5. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China

Description

We investigated the epidemiologic impact, cost-effectiveness, and budget impact of hypothetical novel prophylactic prevention of disease TB vaccines on RR/MDR-TB in China and India.
WHO goals and milestones
Availability, Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
China, India
Timeline
Target group
adolescents, General Adults, People with AMR-TB
Vaccine
Hypothetical vaccines
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling
Partners involved
UK MRC; Aeras; IAVI; LSHTM; Sanofi Pasteur; Chinese CDC; WHO; National TB elimination programme India; BMGF
Type of project

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?